Dopamine Plasma Membrane Transport Proteins

"Dopamine Plasma Membrane Transport Proteins" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Sodium chloride-dependent neurotransmitter symporters located primarily on the PLASMA MEMBRANE of dopaminergic neurons. They remove DOPAMINE from the EXTRACELLULAR SPACE by high affinity reuptake into PRESYNAPTIC TERMINALS and are the target of DOPAMINE UPTAKE INHIBITORS.

Descriptor ID	D050483
MeSH Number(s)	D12.776.157.530.450.625.124 D12.776.157.530.562.374.500.500 D12.776.157.530.937.500 D12.776.543.585.450.625.124 D12.776.543.585.562.374.500.500 D12.776.543.585.937.500
Concept/Terms	Dopamine Plasma Membrane Transport Proteins Dopamine Plasma Membrane Transport Proteins Dopamine Transporter Transporter, Dopamine SLC6A3 Protein Protein, SLC6A3 Solute Carrier Family 6 (Neurotransmitter Transporter), Member 3 Protein Dopamine Transporter Proteins Transporter Proteins, Dopamine Dopamine Carriers Carriers, Dopamine DAT Dopamine Transporter Proteins Neurotransmitter Transport Proteins, Dopamine-Specific Neurotransmitter Transport Proteins, Dopamine Specific Neurotransmitter Transporters, Dopamine-Specific Dopamine-Specific Neurotransmitter Transporters Neurotransmitter Transporters, Dopamine Specific Transporters, Dopamine-Specific Neurotransmitter DAT Dopamine Transporter Dopamine Transporter, DAT Transporter, DAT Dopamine Dopamine Plasma Membrane Transporter Proteins Dopamine Uptake Complex Dopamine Uptake Complex

Below are MeSH descriptors whose meaning is more general than "Dopamine Plasma Membrane Transport Proteins".

Chemicals and Drugs [D]
Amino Acids, Peptides, and Proteins [D12]
Proteins [D12.776]
Carrier Proteins [D12.776.157]
Membrane Transport Proteins [D12.776.157.530]
Ion Pumps [D12.776.157.530.450]
Symporters [D12.776.157.530.450.625]
Dopamine Plasma Membrane Transport Proteins [D12.776.157.530.450.625.124]
Neurotransmitter Transport Proteins [D12.776.157.530.562]
Plasma Membrane Neurotransmitter Transport Proteins [D12.776.157.530.562.374]
Catecholamine Plasma Membrane Transport Proteins [D12.776.157.530.562.374.500]
Dopamine Plasma Membrane Transport Proteins [D12.776.157.530.562.374.500.500]
Solute Carrier Proteins [D12.776.157.530.937]
Dopamine Plasma Membrane Transport Proteins [D12.776.157.530.937.500]
Membrane Proteins [D12.776.543]
Membrane Transport Proteins [D12.776.543.585]
Ion Pumps [D12.776.543.585.450]
Symporters [D12.776.543.585.450.625]
Dopamine Plasma Membrane Transport Proteins [D12.776.543.585.450.625.124]
Neurotransmitter Transport Proteins [D12.776.543.585.562]
Plasma Membrane Neurotransmitter Transport Proteins [D12.776.543.585.562.374]
Catecholamine Plasma Membrane Transport Proteins [D12.776.543.585.562.374.500]
Dopamine Plasma Membrane Transport Proteins [D12.776.543.585.562.374.500.500]
Solute Carrier Proteins [D12.776.543.585.937]
Dopamine Plasma Membrane Transport Proteins [D12.776.543.585.937.500]

Below are MeSH descriptors whose meaning is related to "Dopamine Plasma Membrane Transport Proteins".

Below are MeSH descriptors whose meaning is more specific than "Dopamine Plasma Membrane Transport Proteins".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Dopamine Plasma Membrane Transport Proteins" by people in this website by year, and whether "Dopamine Plasma Membrane Transport Proteins" was a major or minor topic of these publications.

Bar chart showing 34 publications over 18 distinct years, with a maximum of 4 publications in 2005 and 2008

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1998	0	1	1
2000	0	1	1
2001	0	1	1
2003	0	2	2
2004	0	3	3
2005	1	3	4
2006	0	1	1
2007	3	0	3
2008	1	3	4
2009	0	1	1
2011	2	0	2
2012	1	1	2
2013	0	1	1
2014	0	3	3
2015	1	0	1
2016	0	2	2
2017	1	0	1
2019	1	0	1

Below are the most recent publications written about "Dopamine Plasma Membrane Transport Proteins" by people in Profiles.

Monti DA, Zabrecky G, Kremens D, Liang TW, Wintering NA, Bazzan AJ, Zhong L, Bowens BK, Chervoneva I, Intenzo C, Newberg AB. N-Acetyl Cysteine Is Associated With Dopaminergic Improvement in Parkinson's Disease. Clin Pharmacol Ther. 2019 10; 106(4):884-890.

View in: PubMed
Baumann MH, Bukhari MO, Lehner KR, Anizan S, Rice KC, Concheiro M, Huestis MA. Neuropharmacology of 3,4-Methylenedioxypyrovalerone (MDPV), Its Metabolites, and Related Analogs. Curr Top Behav Neurosci. 2017; 32:93-117.

View in: PubMed
Isaacson SH, Fisher S, Gupta F, Hermanowicz N, Kremens DE, Lew MF, Marek K, Pahwa R, Russell DS, Seibyl J. Clinical utility of DaTscan? imaging in the evaluation of patients with parkinsonism: a US perspective. Expert Rev Neurother. 2017 03; 17(3):219-225.

View in: PubMed
Monti DA, Zabrecky G, Kremens D, Liang TW, Wintering NA, Cai J, Wei X, Bazzan AJ, Zhong L, Bowen B, Intenzo CM, Iacovitti L, Newberg AB. N-Acetyl Cysteine May Support Dopamine Neurons in Parkinson's Disease: Preliminary Clinical and Cell Line Data. PLoS One. 2016; 11(6):e0157602.

View in: PubMed
Schneider JS, Cambi F, Gollomp SM, Kuwabara H, Bra?ic JR, Leiby B, Sendek S, Wong DF. GM1 ganglioside in Parkinson's disease: Pilot study of effects on dopamine transporter binding. J Neurol Sci. 2015 Sep 15; 356(1-2):118-23.

View in: PubMed
Doty RL, Gandhi SS, Osman A, Hurtig HI, Pawasarat I, Beals E, Chung I, Dubroff J, Newberg A, Ying GS, Leon-Sarmiento FE. Point pressure sensitivity in early stage Parkinson's disease. Physiol Behav. 2015 Jan; 138:21-7.

View in: PubMed
Simpson EH, Morud J, Winiger V, Biezonski D, Zhu JP, Bach ME, Malleret G, Polan HJ, Ng-Evans S, Phillips PE, Kellendonk C, Kandel ER. Genetic variation in COMT activity impacts learning and dopamine release capacity in the striatum. Learn Mem. 2014 Mar 17; 21(4):205-14.

View in: PubMed
Newberg AB, Serruya M, Gepty A, Intenzo C, Lewis T, Amen D, Russell DS, Wintering N. Clinical comparison of 99mTc exametazime and 123I Ioflupane SPECT in patients with chronic mild traumatic brain injury. PLoS One. 2014; 9(1):e87009.

View in: PubMed
Phani S, Jablonski M, Pelta-Heller J, Cai J, Iacovitti L. Gremlin is a novel VTA derived neuroprotective factor for dopamine neurons. Brain Res. 2013 Mar 15; 1500:88-98.

View in: PubMed
Amsterdam JD, Newberg AB, Soeller I, Shults J. Greater striatal dopamine transporter density may be associated with major depressive episode. J Affect Disord. 2012 Dec 10; 141(2-3):425-31.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement